Bevacizumab in Combination with FOLFIRI in the First-Line Treatment of Patients with Advanced Colorectal Cancer: A Single-Institution Experience. Journal of Analytical Oncology, [S. l.], v. 3, n. 1, p.  26–32, 2014. DOI: 10.6000/1927-7229.2014.03.01.4. Disponível em: https://neoplasiaresearch.com/index.php/jao/article/view/209. Acesso em: 19 apr. 2026.